Literature DB >> 19826122

Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval.

Alberto Sobrero1, Paolo Bruzzi.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19826122     DOI： 10.1200/JCO.2009.22.4162

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  28 in total

Review 1.  Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design.

Authors:  Jaap Verweij; Maja de Jonge; Ferry Eskens; Stefan Sleijfer
Journal:  Mol Oncol       Date:  2012-02-16       Impact factor: 6.603

2.  Green oncology: cultivating sustainability in medical oncology.

Authors:  Salvatore Palazzo; Antonio Jirillo; Magdalena Mazurek
Journal:  J Gastrointest Cancer       Date:  2012-03

Review 3.  Benefit and harms of new anti-cancer drugs.

Authors:  Francisco E Vera-Badillo; Mustafa Al-Mubarak; Arnoud J Templeton; Eitan Amir
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

4.  Leveling the playing field: bringing development of biomarkers and molecular diagnostics up to the standards for drug development.

Authors:  George Poste; David P Carbone; David R Parkinson; Jaap Verweij; Stephen M Hewitt; J Milburn Jessup
Journal:  Clin Cancer Res       Date:  2012-03-15       Impact factor: 12.531

5.  Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists.

Authors:  C Camps-Herrero; L Paz-Ares; M Codes; R López-López; A Antón-Torres; P Gascón-Vilaplana; V Guillem-Porta; A Carrato; J J Cruz-Hernández; C Caballero-Díaz; A Blasco-Cordellat; J A Moreno-Nogueira; E Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2014-06-13       Impact factor: 3.405

Review 6.  Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors:  Helen Gharwan; Hunter Groninger
Journal:  Nat Rev Clin Oncol       Date:  2015-12-31       Impact factor: 66.675

7.  Biological drugs for the treatment of rheumatoid arthritis by the subcutaneous route: interpreting efficacy data to assess statistical equivalence.

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli; Roberta Gatto; Mauro De Rosa; Claudio Marinai
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-12       Impact factor: 5.346

8.  Five steps for structural reform in clinical cancer research.

Authors:  Alastair Matheson
Journal:  Am J Public Health       Date:  2010-02-18       Impact factor: 9.308

9.  Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural Nebraska.

Authors:  Mehmet Sitki Copur; Ryan Ramaekers; Mithat Gönen; Mary Gulzow; Rebecca Hadenfeldt; Courtney Fuller; Jenifer Scott; Sarah Einspahr; Heather Benzel; Mary Mickey; Max Norvell; Douglas Clark; Dron Gauchan; Dax Kurbegov; Mehmet Sitki Copur; Ryan Ramaekers; Mithat Gönen; Mary Gulzow; Rebecca Hadenfeldt; Courtney Fuller; Jenifer Scott; Sarah Einspahr; Heather Benzel; Mary Mickey; Max Norvell; Douglas Clark; Dron Gauchan; Dax Kurbegov
Journal:  J Oncol Pract       Date:  2015-08-11       Impact factor: 3.840

10.  The ethical problem of randomization.

Authors:  Agostino Colli; Luigi Pagliaro; Piergiorgio Duca
Journal:  Intern Emerg Med       Date:  2014-09-07       Impact factor: 3.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.